David Sánz-Rubio

578 total citations
32 papers, 389 citations indexed

About

David Sánz-Rubio is a scholar working on Molecular Biology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David Sánz-Rubio has authored 32 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 19 papers in Physiology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David Sánz-Rubio's work include Obstructive Sleep Apnea Research (16 papers), Extracellular vesicles in disease (14 papers) and Prion Diseases and Protein Misfolding (7 papers). David Sánz-Rubio is often cited by papers focused on Obstructive Sleep Apnea Research (16 papers), Extracellular vesicles in disease (14 papers) and Prion Diseases and Protein Misfolding (7 papers). David Sánz-Rubio collaborates with scholars based in Spain, United States and France. David Sánz-Rubio's co-authors include José M. Marı́n, Abdelnaby Khalyfa, Inmaculada Martín‐Burriel, Pablo Cubero, Marta Forner, David Gozal, Rosa Bolea, Zhuanhong Qiao, David Gozal and Óscar López-Pérez and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and European Respiratory Journal.

In The Last Decade

David Sánz-Rubio

29 papers receiving 388 citations

Peers

David Sánz-Rubio
Prashant J. Ruchaya United Kingdom
Yewen Shi China
Lloyd White Australia
Casey L. Egan Australia
Mason A. Norgard United States
David Sánz-Rubio
Citations per year, relative to David Sánz-Rubio David Sánz-Rubio (= 1×) peers Qingqing Yin

Countries citing papers authored by David Sánz-Rubio

Since Specialization
Citations

This map shows the geographic impact of David Sánz-Rubio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sánz-Rubio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sánz-Rubio more than expected).

Fields of papers citing papers by David Sánz-Rubio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Sánz-Rubio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sánz-Rubio. The network helps show where David Sánz-Rubio may publish in the future.

Co-authorship network of co-authors of David Sánz-Rubio

This figure shows the co-authorship network connecting the top 25 collaborators of David Sánz-Rubio. A scholar is included among the top collaborators of David Sánz-Rubio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Sánz-Rubio. David Sánz-Rubio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Forner, Marta, Marta Marín‐Oto, Pedro M. Baptista, et al.. (2025). Peripheral Extracellular Vesicles for Diagnosis and Prognosis of Resectable Lung Cancer: The LUCEx Study Protocol. Journal of Clinical Medicine. 14(2). 411–411.
2.
Herrero‐Cortina, Beatriz, et al.. (2024). Incident Cardiometabolic Comorbidities in Smokers with/Without Chronic Obstructive Pulmonary Disease: A Long-Term Cohort Study. Journal of Clinical Medicine. 13(24). 7627–7627. 1 indexed citations
3.
Moreno‐Martínez, Laura, David Sánz-Rubio, P. Zaragoza, et al.. (2024). Analysis of Plasma-Derived Exosomal MicroRNAs as Potential Biomarkers for Canine Idiopathic Epilepsy. Animals. 14(2). 252–252. 2 indexed citations
4.
Khalyfa, Abdelnaby, José M. Marı́n, David Sánz-Rubio, et al.. (2023). Multi-Omics Analysis of Circulating Exosomes in Adherent Long-Term Treated OSA Patients. International Journal of Molecular Sciences. 24(22). 16074–16074. 9 indexed citations
5.
Díaz‐García, Elena, Aldara García‐Sánchez, David Sánz-Rubio, et al.. (2023). SMAD4 Expression in Monocytes as a Potential Biomarker for Atherosclerosis Risk in Patients with Obstructive Sleep Apnea. International Journal of Molecular Sciences. 24(9). 7900–7900. 2 indexed citations
6.
Gu, Wanjun, Jorge A. Masso-Silva, David Sánz-Rubio, et al.. (2023). Inflammation biomarkers in OSA, chronic obstructive pulmonary disease, and chronic obstructive pulmonary disease/OSA overlap syndrome. Journal of Clinical Sleep Medicine. 19(8). 1447–1456. 22 indexed citations
7.
Sánz-Rubio, David, et al.. (2022). Effect of positive pressure ventilation and bariatric surgery on extracellular vesicle microRNAs in patients with severe obesity and obstructive sleep apnea. International Journal of Obesity. 47(1). 24–32. 1 indexed citations
8.
Marín‐Oto, Marta, David Sánz-Rubio, Iván D. Benítez, et al.. (2022). Soluble RAGE in COPD, with or without coexisting obstructive sleep apnoea. Respiratory Research. 23(1). 163–163. 3 indexed citations
9.
Díaz‐García, Elena, David Sánz-Rubio, Enrique Alfaro, et al.. (2022). Inflammasome activation mediated by oxidised low-density lipoprotein in patients with sleep apnoea and early subclinical atherosclerosis. European Respiratory Journal. 61(3). 2201401–2201401. 24 indexed citations
10.
Khalyfa, Abdelnaby & David Sánz-Rubio. (2021). The Mystery of Red Blood Cells Extracellular Vesicles in Sleep Apnea with Metabolic Dysfunction. International Journal of Molecular Sciences. 22(9). 4301–4301. 13 indexed citations
11.
López-Pérez, Óscar, David Sánz-Rubio, Alicia Otero, et al.. (2021). Cerebrospinal Fluid and Plasma Small Extracellular Vesicles and miRNAs as Biomarkers for Prion Diseases. International Journal of Molecular Sciences. 22(13). 6822–6822. 16 indexed citations
12.
Marı́n, José M., et al.. (2021). Extracellular Vesicles from Airway Secretions: New Insights in Lung Diseases. International Journal of Molecular Sciences. 22(2). 583–583. 30 indexed citations
13.
Sánz-Rubio, David, Abdelnaby Khalyfa, Zhuanhong Qiao, et al.. (2021). Cell-Selective Altered Cargo Properties of Extracellular Vesicles Following In Vitro Exposures to Intermittent Hypoxia. International Journal of Molecular Sciences. 22(11). 5604–5604. 13 indexed citations
14.
Sánz-Rubio, David, Francisco José Vázquez, Óscar López-Pérez, et al.. (2021). Effect of Scrapie Prion Infection in Ovine Bone Marrow-Derived Mesenchymal Stem Cells and Ovine Mesenchymal Stem Cell-Derived Neurons. Animals. 11(4). 1137–1137. 3 indexed citations
15.
Khalyfa, Abdelnaby, Wojciech Trzépizur, Alex Gileles‐Hillel, et al.. (2021). Heterogeneity of Melanoma Cell Responses to Sleep Apnea-Derived Plasma Exosomes and to Intermittent Hypoxia. Cancers. 13(19). 4781–4781. 10 indexed citations
16.
Toivonen, Janne M., David Sánz-Rubio, Óscar López-Pérez, et al.. (2020). MicroRNA Alterations in a Tg501 Mouse Model of Prion Disease. Biomolecules. 10(6). 908–908. 8 indexed citations
17.
Sánz-Rubio, David, A. Sanz, L. Varona, et al.. (2020). Forkhead Box P3 Methylation and Expression in Men with Obstructive Sleep Apnea. International Journal of Molecular Sciences. 21(6). 2233–2233. 5 indexed citations
18.
Sánz-Rubio, David, et al.. (2020). Epigenetics dysfunction in morbid obesity with or without obstructive sleep apnoea: the EPIMOOSA study. Respiratory Research. 21(1). 42–42. 3 indexed citations
19.
López-Pérez, Óscar, Alicia Otero, David Sánz-Rubio, et al.. (2019). Dysregulation of autophagy in the central nervous system of sheep naturally infected with classical scrapie. Scientific Reports. 9(1). 1911–1911. 21 indexed citations
20.
Khalyfa, Abdelnaby & David Sánz-Rubio. (2019). Genetics and Extracellular Vesicles of Pediatrics Sleep Disordered Breathing and Epilepsy. International Journal of Molecular Sciences. 20(21). 5483–5483. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026